The precise clinical evaluation of anti-cancer mechanisms of pure flavonoids or flavonoid-rich herbs mediated via NF-κB is essential for the effective search of novel adjuvant agents with possible action on overcoming MDR within combinational strategies with conventional chemotherapeutic drugs in BC management. This evidence concerns the gene NFKB1 and cancer.